Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole and voriconazole effects on sublingual buprenorphine pharmacokinetics and pharmacodynamics in healthy adults
2010-020953-14Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of buprenorphine, posaconazole and voriconazole (3 arms), sponsored by Turku University Hospital. Primary endpoints: Pharmacokinetic measurements and Pharmacodynamic measurements. Started Jun 2010; status: completed.
02
Drugs
buprenorphineposaconazolevoriconazole
Beyond the preview
Go deeper on 2010-020953-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020953-14.